American Academy of Dermatology

Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks

Posted on: 09/04/2015 - 15:18

SAN FRANCISCO – More than 80% of psoriasis patients who received ixekizumab achieved a 75% reduction in the Psoriasis Area and Severity Index score ... More »

Field of Interest: Dermatology

Type: News Item

Weekly adalimumab at 40 mg works best for hidradenitis suppurativa

Posted on: 01/04/2015 - 13:24

SAN FRANCISCO – Weekly treatment with 40 mg of adalimumab yielded the strongest clinical responses in adults with moderate to severe hidradenitis su... More »

Field of Interest: Dermatology

Type: News Item

Dupilumab improves moderate to severe atopic dermatitis in adults

Posted on: 22/03/2015 - 19:24

SAN FRANCISCO– Dupilumab met its safety endpoints and significantly outperformed placebo for adults with moderate to severe atopic dermatitis, accor... More »

Field of Interest: Dermatology

Type: News Item

Evolving nanotechnology reveals potential treatment advantages

Posted on: 22/05/2014 - 18:05

DENVER – As the nanotechnology field evolves, there are at least three reasons a clinician might prefer to use nanoparticles over conventional drugs, according to Dr. Jack L. Arbiser. The first is to...

Field of Interest: Dermatology

Type: News Item

Try tackling cysts or lipomas with punch tool instead of scalpel

Posted on: 14/04/2014 - 18:10

DENVER – A little lidocaine and a punch biopsy tool allow physicians to tackle most cysts and lipomas in the office, providing effective treatment without interrupting patient flow. The punch...

Field of Interest: Dermatology

Type: News Item

Investigational acne treatment targets the sebaceous gland

Posted on: 02/04/2014 - 21:31

DENVER – In the not-so-distant future, a treatment option for patients with moderate to severe acne may involve destruction of the sebaceous gland, according to Dr. R. Rox Anderson, director of the...

Field of Interest: Dermatology

Type: News Item

What’s old is new again for actinic keratoses treatment

Posted on: 31/03/2014 - 23:00

DENVER – Changes in health insurance coverage are prompting a resurgence in the use of 5-fluorouracil to treat actinic keratoses, according to Dr. Linda Susan Marcus. Not only is 5-fluorouracil...

Field of Interest: Dermatology

Type: News Item

VIDEO: Battlefield lessons improve treatment of traumatic scars

Posted on: 25/03/2014 - 20:50

DENVER – Military dermatologists have played an active role in helping wounded warriors with their scars, and those physicians’ practices, including the use of ablative fractional resurfacing, are...

Field of Interest: Dermatology

Type: News Item

Tofacitinib found noninferior to etanercept for treating psoriasis

Posted on: 25/03/2014 - 17:10

DENVER – Key results from a phase III trial found that an investigational Janus kinase inhibitor was noninferior to a biologic agent for treating psoriasis. During a late-breaking session at the...

Field of Interest: Dermatology

Type: News Item

Novel agent for papulopustular rosacea found safe, effective in phase III trials

Posted on: 23/03/2014 - 19:50

DENVER – Ivermectin 1% cream applied once daily was effective and safe in treating patients with moderate to severe papulopustular rosacea, based on data from a pair of phase III studies. Ivermectin...

Field of Interest: Dermatology

Type: News Item

Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks

Weekly adalimumab at 40 mg works best for hidradenitis suppurativa

Dupilumab improves moderate to severe atopic dermatitis in adults

Evolving nanotechnology reveals potential treatment advantages

Try tackling cysts or lipomas with punch tool instead of scalpel

Investigational acne treatment targets the sebaceous gland

What’s old is new again for actinic keratoses treatment

VIDEO: Battlefield lessons improve treatment of traumatic scars

Tofacitinib found noninferior to etanercept for treating psoriasis

Novel agent for papulopustular rosacea found safe, effective in phase III trials

Newsletters

Latest Newsletters

You are here

American Academy of Dermatology

Newsletters

Latest Newsletters